Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corcept Therapeutics Inc shares valued at $2,914,000 were purchased by BELANOFF JOSEPH K on Jul 17 ’25. At $72.85 per share, BELANOFF JOSEPH K acquired 40,000 shares.
Also, Swisher Daniel N JR sold 2,200 shares, netting a total of over 156,376 in proceeds. Following the sale of shares at $71.08 each, the insider now holds 0 shares.
Before that, Swisher Daniel N JR had added 2,200 shares to its account. In a trade valued at $156,376, the Director bought Corcept Therapeutics Inc shares for $71.08 each.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
On last trading session,, Corcept Therapeutics Inc [NASDAQ: CORT] rose 0.34% to $73.1. The stock’s lowest price that day was $72.41, but it reached a high of $73.78 in the same session. During the last five days, there has been a surge of approximately 1.51%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 125.97%.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
RSI (Relative Strength Index) is 53.11 on the 14-day chart, showing neutral technical sentiment.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.17 million shares to 12.65 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 12.48 million shares. A jump of 1.35% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.21 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.21.
Which companies own the most shares of Corcept Therapeutics Inc (CORT)?
In terms of Corcept Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 92.18% from the previous closing price of $72.85. Analysts anticipate Corcept Therapeutics Inc stock to reach 145 by 2025, with the lowest price target being 135. In spite of this, 4 analysts ranked Corcept Therapeutics Inc stock as Buy at the end of 2025. On August 01, 2022, Truist assigned a price target of “a Hold” to the stock and downgraded coverage with a $30.
